Insider · CIK 0001534166
Nicholas Naclerio
Files at ALMR (Alamar Biosciences, Inc.). First filing Apr 20, 2026, latest Apr 20, 2026.
In brief
Nicholas Naclerio files SEC Form 4 as 10% owner and director at ALMR (Alamar Biosciences, Inc.). Since Apr 20, 2026, Nicholas Naclerio has reported 1 open-market buy worth $4.0M and 0 open-market sells worth $0, the latest filed on Apr 20, 2026.
A track record needs three past buys with six months of prices behind them; Nicholas Naclerio has 0, so none is measured yet.
The newest scored trade: bought $4.0M of ALMR on Apr 20, 2026, filed Apr 20, 2026, scored 58 (moderate). In the last 12 months: 1 buy worth $4.0M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALMR: Alamar Biosciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 58Moderate | Alamar Biosciences, Inc. | $4.0M 235,294 shares | +87% | - |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Class B Common Stockindirect: See footnote | +4,588,364 | - | - | 4,588,364 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Class B Common Stockindirect: See footnote | +922,152 | - | - | 5,510,516 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Class B Common Stockindirect: See footnote | -5,510,516 | - | - | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Common Stockindirect: See footnote | +5,510,516 | - | - | 5,510,516 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Common Stockindirect: See footnote | +346,020 | - | - | 5,856,536 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Common Stockindirect: See footnote | +271,782 | - | - | 271,782 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | POpen-market purchase Common Stockindirect: See footnote | +235,294 | $17.00 | $4.0M | 507,076 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | AGrant or award Common Stock | +5,686 | $0.00 | $0 | 5,686 | Apr 20, 2026 |
| Apr 16, 2026 | ALMR Alamar Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +25,599 | $0.00 | $0 | 25,599 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series A-3 Preferred Stockderivativeindirect: See footnote | -3,194,377 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series A-4 Preferred Stockderivativeindirect: See footnote | -2,862,507 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series B Preferred Stockderivativeindirect: See footnote | -2,094,266 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series C Preferred Stockderivativeindirect: See footnote | -5,037,783 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Convertible Promissory Notederivativeindirect: See footnote | - | $0.00 | - | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Convertible Promissory Notederivativeindirect: See footnote | - | $0.00 | - | 0 | Apr 20, 2026 |
Questions about Nicholas Naclerio
Answered from the filings on this page, as of the latest one.
Is Nicholas Naclerio buying or selling?
In the last 12 months Nicholas Naclerio reported 1 open-market buy worth $4.0M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $4.0M of ALMR on Apr 20, 2026. Grants, option exercises and tax withholding are not counted.
How did Nicholas Naclerio's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nicholas Naclerio has 0.
Where does Nicholas Naclerio file Form 4?
Nicholas Naclerio has filed Form 4 at ALMR (Alamar Biosciences, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.